MeSH D006951 - hyperlipoproteinemias
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D006949:Hyperlipidemias
0 Companies
0 Drugs
Success rate
D006951:Â
Hyperlipoproteinemias
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Fenofibrate | Tricor |  | 1993-12-31 | $606 M | Q3/12-Q3/13 |
| Accord Healthcare | Pravastatin | Pravastatin |  | 2016-11-17 |  |  |
| Rosuvastatin | Rosuvastatin |  | 2016-10-31 |  |  | |
| Ajanta Pharma | Fenofibrate | Fenofibrate |  | 2018-07-23 |  |  |
| Alembic Pharmaceuticals | Fenofibrate | Fenofibrate |  | 2019-08-09 |  |  |
| Alkem Laboratories | Ezetimibe, Simvastatin | Ezetimibe Simvastatin |  | 2017-12-22 |  |  |
| Rosuvastatin | Rosuvastatin |  | 2017-03-21 |  |  | |
| Allergan | Ezetimibe, Simvastatin | Ezetimibe Simvastatin |  | 2017-04-26 |  |  |
| Pravastatin | Pravastatin |  | 2006-10-23 |  |  | |
| Rosuvastatin | Rosuvastatin |  | 2016-04-29 |  |  | |
| Althera Pharmaceutical | Ezetimibe, Rosuvastatin | Roszet | 2033-05-01 | 2021-03-23 |  |  |
| Amneal Pharmaceuticals | Ezetimibe, Simvastatin | Ezetimibe Simvastatin |  | 2017-11-21 |  |  |
| Fenofibrate | Fenofibrate |  | 2018-03-19 |  |  | |
| Rosuvastatin | Rosuvastatin |  | 2018-10-16 |  |  |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
50%1/2
Phase 3
86%19/22
Approved: 16Overall Success rate: 43%
All Clinical Trials
No data
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use